FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

430306004: Certolizumab pegol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2708529014 Certolizumab pegol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764885014 Certolizumab pegol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
799481000172116 certolizumab pégol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
799491000172118 certolizumab pegol nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Certolizumab pegol (substance) Is a Inflammatory bowel disease agent false Inferred relationship Some
Certolizumab pegol (substance) Is a Monoclonal antibody agent false Inferred relationship Some
Certolizumab pegol (substance) Is a Monoclonal antibody true Inferred relationship Some
Certolizumab pegol (substance) Is a Gastrointestinal agent (substance) true Inferred relationship Some
Certolizumab pegol (substance) Has disposition (attribute) Tumor necrosis factor alpha inhibitor (disposition) true Inferred relationship Some
Certolizumab pegol (substance) Is a Tumor necrosis factor alpha inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing certolizumab pegol (medicinal product) Has active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Certolizumab pegol 200mg powder for injection solution vial + diluent Has active ingredient False Certolizumab pegol (substance) Inferred relationship Some
Certolizumab pegol therapy (procedure) Direct substance True Certolizumab pegol (substance) Inferred relationship Some 2
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Certolizumab pegol (substance) Inferred relationship Some
Product containing only certolizumab pegol (medicinal product) Has active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing certolizumab pegol in parenteral dose form (medicinal product form) Has active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Certolizumab pegol only product in parenteral dose form Has active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Certolizumab pegol (substance) Inferred relationship Some 1
Product containing precisely certolizumab pegol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Certolizumab pegol (substance) Inferred relationship Some 1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start